HLA-DQ8 (DQB1*0302)-restricted Th17 cells exacerbate experimental autoimmune encephalomyelitis in HLA-DR3-transgenic mice

Journal of Immunology

Volumn 182, Issue 8, 2009, Pages 5131-5139

  Mangalam, Ashutosh ^a   Luckey, David ^a   Basal, Eati ^a   Jackson, Megan ^a,c   Smart, Michele ^a   Rodriguez, Moses ^a,b   David, Chella ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b Mayo Clinic College of Medicine   (United States)

^c BEREA COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA DQ8 ANTIGEN; HLA DR3 ANTIGEN; PROTEOLIPID PROTEIN; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; INTERLEUKIN 17;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DISEASE MODEL; DISEASE PREDISPOSITION; DISEASE SEVERITY; MORBIDITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; TH17 CELL; ANIMAL; CELL MOTION; CYTOLOGY; GENETICS; HELPER CELL; IMMUNOLOGY; METABOLISM; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; CELL MOVEMENT; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DQ ANTIGENS; HLA-DR3 ANTIGEN; INTERFERON-GAMMA; INTERLEUKIN-17; MICE; MICE, TRANSGENIC; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 65249147878     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803918     Document Type: Article

References (43)

1. Sospedra, M., and R. Martin. 2005. Immunology of multiple sclerosis. Annu. Rev. Immunol. 23: 683-747.
2. Greer, J. M., P. A. Csurhes, K. D. Cameron, P. A. McCombe, M. F. Good, and M. P. Pender. 1997. Increased immunoreactivity to two overlapping peptides of myelin proteolipid protein in multiple sclerosis. Brain 120: 1447-1460. (Pubitemid 27344711)
3. Martino, G., and H. P. Hartung. 1999. Immunopathogenesis of multiple sclerosis: the role of T cells. Curr. Opin. Neurol. 12: 309-321. (Pubitemid 29378165)
4. Schmidt, S. 1999. Candidate autoantigens in multiple sclerosis. In Multiple Sclerosis, Vol. 5. Houndmills, Basingstoke, U.K., pp. 147-160.
5. McDonald, W. I. 1984. Multiple sclerosis: epidemiology and HLA associations. Ann. NY Acad. Sci. 436: 109-117. (Pubitemid 15102036)
6. Oksenberg, J. R., A. B. Begovich, H. A. Erlich, and L. Steinman. 1993. Genetic factors in multiple sclerosis. JAMA 270: 2362-2369.
7. Barcellos, L. F., S. Sawcer, P. P. Ramsay, S. E. Baranzini, G. Thomson, F. Briggs, B. C. Cree, A. B. Begovich, P. Villoslada, X. Montalban, et al. 2006. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum. Mol. Genet. 15: 2813-2824. (Pubitemid 44400408)
8. Dyment, D. A., A. D. Sadovnick, and G. C. Ebers. 1997. Genetics of multiple sclerosis. Hum. Mol. Genet. 6: 1693-1698.
9. Weinshenker, B. G., P. Santrach, A. S. Bissonet, S. K. McDonnell, D. Schaid, S. B. Moore, and M. Rodriguez. 1998. Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study. Neurology 51: 742-747. (Pubitemid 28449253)
10. Marrosu, M. G., F. Muntoni, M. R. Murru, G. Spinicci, M. P. Pischedda, F. Goddi, P. Cossu, and M. Pirastu. 1988. Sardinian multiple sclerosis is associated with HLA-DR4: a serologic and molecular analysis. Neurology 38: 1749-1753.
11. Marrosu, M. G., M. R. Murru, G. Costa, F. Cucca, S. Sotgiu, G. Rosati, and F. Muntoni. 1997. Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and -DR4 alleles. Am. J. Hum. Genet. 61: 454-457.
12. Alvarado-de la Barrera, C., J. Zuniga-Ramos, J. A. Ruiz-Morales, B. Estanol, J. Granados, and L. Llorente. 2000. HLA class II genotypes in Mexican Mestizos with familial and nonfamilial multiple sclerosis. Neurology 55: 1897-1900.
13. Zivadinov, R., L. Uxa, A. Bratina, A. Bosco, B. Srinivasaraghavan, A. Minagar, M. Ukmar, S. Benedetto, and M. Zorzon. 2007. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis. Int. Rev. Neurobiol. 79: 521-535.
14. Dyment, D. A., B. M. Herrera, M. Z. Cader, C. J. Willer, M. R. Lincoln, A. D. Sadovnick, N. Risch, and G. C. Ebers. 2005. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum. Mol. Genet. 14: 2019-2026.
15. Cullen, C. G., D. Middleton, D. A. Savage, and S. Hawkins. 1991. HLA-DR and DQ DNA genotyping in multiple sclerosis patients in Northern Ireland. Hum. Immunol. 30: 1-6.
16. Masterman, T., A. Ligers, T. Olsson, M. Andersson, O. Olerup, and J. Hillert. 2000. HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann. Neurol. 48: 211-219. (Pubitemid 30617040)
17. Chao, M. J., M. C. Barnardo, M. R. Lincoln, S. V. Ramagopalan, B. M. Herrera, D. A. Dyment, A. Montpetit, A. D. Sadovnick, J. C. Knight, and G. C. Ebers. 2008. HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility. Proc. Natl. Acad. Sci. USA 105: 13069-13074.
18. DeLuca, G. C., S. V. Ramagopalan, B. M. Herrera, D. A. Dyment, M. R. Lincoln, A. Montpetit, M. Pugliatti, M. C. Barnardo, N. J. Risch, A. D. Sadovnick, et al. 2007. An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus. Proc. Natl. Acad. Sci. USA 104: 20896-20901.
19. Ramagopalan, S. V., G. C. Deluca, K. M. Morrison, B. M. Herrera, D. A. Dyment, M. R. Lincoln, S. M. Orton, M. J. Chao, A. Degenhardt, M. Pugliatti, et al. 2008. Analysis of 45 candidate genes for disease modifying activity in multiple sclerosis. J. Neurol. 255: 1215-1219.
20. Ramagopalan, S. V., A. P. Morris, D. A. Dyment, B. M. Herrera, G. C. DeLuca, M. R. Lincoln, S. M. Orton, M. J. Chao, A. D. Sadovnick, and G. C. Ebers. 2007. The inheritance of resistance alleles in multiple sclerosis. PLoS Genet. 3: 1607-1613. (Pubitemid 47510254)
21. Mangalam, A. K., M. Khare, C. Krco, M. Rodriguez, and C. David. 2004. Identification of T cell epitopes on human proteolipid protein and induction of experimental autoimmune encephalomyelitis in HLA class II-transgenic mice. Eur. J. Immunol. 34: 280-290.
22. Klehmet, J., C. Shive, R. Guardia-Wolff, I. Petersen, E. G. Spack, B. O. Boehm, R. Weissert, and T. G. Forsthuber. 2004. T cell epitope spreading to myelin oligodendrocyte glycoprotein in HLA-DR4 transgenic mice during experimental autoimmune encephalomyelitis. Clin. Immunol. 111: 53-60. (Pubitemid 38482082)
23. Madsen, L. S., E. C. Andersson, L. Jansson, M. Krogsgaard, C. B. Andersen, J. Engberg, J. L. Strominger, A. Svejgaard, J. P. Hjorth, R. Holmdahl, et al. 1999. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor. Nat. Genet. 23: 343-347.
24. Khare, M., A. Mangalam, M. Rodriguez, and C. S. David. 2005. HLA DR and DQ interaction in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in HLA class II transgenic mice. J. Neuroimmunol. 169: 1-12. (Pubitemid 41527086)
25. Mangalam, A. K., G. Rajagopalan, V. Taneja, and C. S. David. 2008. HLA class II transgenic mice mimic human inflammatory diseases. Adv. Immunol. 97: 65-147.
26. Amirzargar, A., J. Mytilineos, A. Yousefipour, S. Farjadian, S. Scherer, G. Opelz, and A. Ghaderi. 1998. HLA class II (DRB1, DQA1 and DQB1) associated genetic susceptibility in Iranian multiple sclerosis (MS) patients. Eur. J. Immunogenet. 25: 297-301. (Pubitemid 28408293)
27. Herrera, B. M., and G. C. Ebers. 2003. Progress in deciphering the genetics of multiple sclerosis. Curr. Opin. Neurol. 16: 253-258. (Pubitemid 36688290)
28. Das, P., K. M. Drescher, A. Geluk, D. S. Bradley, M. Rodriguez, and C. S. David. 2000. Complementation between specific HLA-DR and HLA-DQ genes in transgenic mice determines susceptibility to experimental autoimmune encephalomyelitis. Hum. Immunol. 61: 279-289. (Pubitemid 30117795)
29. Oksenberg, J. R., L. F. Barcellos, B. A. Cree, S. E. Baranzini, T. L. Bugawan, O. Khan, R. R. Lincoln, A. Swerdlin, E. Mignot, L. Lin, et al. 2004. Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans. Am. J. Hum. Genet. 74: 160-167. (Pubitemid 38085247)
30. Serjeantson, S. W., X. Gao, B. R. Hawkins, D. A. Higgins, and Y. L. Yu. 1992. Novel HLA-DR2-related haplotypes in Hong Kong Chinese implicate the DQB1*0602 allele in susceptibility to multiple sclerosis. Eur. J. Immunogenet. 19: 11-19.
31. Mangalam, A., D. Luckey, E. Basal, M. Behrens, M. Rodriguez, and C. David. 2008. HLA-DQ6 (DQB1*0601)-restricted T cells protect against experimental autoimmune encephalomyelitis in HLA-DR3.DQ6 double-transgenic mice by generating anti-inflammatory IFN-γ. J. Immunol. 180: 7747-7756.
32. Bradley, D. S., G. H. Nabozny, S. Cheng, P. Zhou, M. M. Griffiths, H. S. Luthra, and C. S. David. 1997. HLA-DQB1 polymorphism determines incidence, onset, and severity of collagen-induced arthritis in transgenic mice. Implications in human rheumatoid arthritis. J. Clin. Invest. 100: 2227-2234.
33. Strauss, G., D. A. Vignali, G. Schonrich, and G. J. Hammerling. 1994. Negative and positive selection by HLA-DR3(DRw17) molecules in transgenic mice. Immunogenetics 40: 104-108. (Pubitemid 24193959)
34. Lampson, L. A., and R. Levy. 1980. Two populations of Ia-like molecules on a human B cell line. J. Immunol. 125: 293-299.
35. Jain, R., D. M. Tartar, R. K. Gregg, R. D. Divekar, J. J. Bell, H. H. Lee, P. Yu, J. S. Ellis, C. M. Hoeman, C. L. Franklin, and H. Zaghouani. 2008. Innocuous IFNγ induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production. J. Exp. Med. 205: 207-215. (Pubitemid 351185727)
36. Olerup, O., J. Hillert, S. Fredrikson, T. Olsson, S. Kam-Hansen, E. Moller, B. Carlsson, and J. Wallin. 1989. Primarily chronic progressive and relapsing/ remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc. Natl. Acad. Sci. USA 86: 7113-7117. (Pubitemid 19240875)
37. Marrosu, M. G., F. Muntoni, M. R. Murru, G. Costa, M. P. Pischedda, M. Pirastu, S. Sotgiu, G. Rosati, and C. Cianchetti. 1992. HLA-DQB1 genotype in Sardinian multiple sclerosis: evidence for a key role of DQB1 *0201 and *0302 alleles. Neurology 42: 883-886.
38. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201: 233-240.
39. Weaver, C. T., R. D. Hatton, P. R. Mangan, and L. E. Harrington. 2007. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25: 821-852.
40. Carlson, T., M. Kroenke, P. Rao, T. E. Lane, and B. Segal. 2008. The Th17- ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease. J. Exp. Med. 205: 811-823. (Pubitemid 351549880)
41. Lees, J. R., Y. Iwakura, and J. H. Russell. 2008. Host T cells are the main producers of IL-17 within the central nervous system during initiation of experimental autoimmune encephalomyelitis induced by adoptive transfer of Th1 cell lines. J. Immunol. 180: 8066-8072.
42. Gold, R., H. P. Hartung, and H. Lassmann. 1997. T-cell apoptosis in autoimmune diseases: termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms. Trends Neurosci. 20: 399-404. (Pubitemid 27364510)
43. Pender, M. P., and M. J. Rist. 2001. Apoptosis of inflammatory cells in immune control of the nervous system: role of glia. Glia 36: 137-144.